A patent is far more than a legal certificate hanging on a wall. In today’s competitive business environment, it is a strategic instrument – one that companies deploy with careful intent to protect their market position, generate revenue, or signal their innovation credentials to investors and partners. The question is not just whether to patent but how to use that patent once you have it. Patent tactics answer exactly that question. Broadly speaking, they fall into three categories: defensive, offensive, and transactional. Each serves a distinct corporate purpose, and understanding the difference is essential for anyone studying intellectual property management.
Table of Contents
- Why patent tactics matter
- Defensive patent tactics
- Building a blocking portfolio
- Defensive publication
- Cross-licensing as a defensive shield
- Freedom to operate (FTO) analysis
- Offensive patent tactics
- Licensing for revenue
- Litigation and enforcement
- Patent fencing and thickets
- Blocking competitors from key technology areas
- Transactional patent tactics
- Patents as collateral for financing
- Buying and selling patents
- Collaborative R&D and joint IP ownership
- Enhancing corporate image and credibility
- Choosing the right mix of tactics
- The Indian context
Why patent tactics matter
Filing a patent application is a significant investment of time and money. Under the Patents Act, 1970 – the primary legislation governing patents in India – a granted patent gives its holder the exclusive right to make, use, sell, and import the patented invention for up to 20 years. That exclusivity is valuable, but its value depends entirely on how the patent is used. A company that files patents without a clear tactical purpose is essentially buying an expensive insurance policy it never reads.
Patent tactics are the deliberate choices companies make about why they file, what they file, and what they do with patents after grant. The three main categories – defensive, offensive, and transactional – are not mutually exclusive. Large technology and pharmaceutical companies routinely combine all three, building patent portfolios that serve multiple simultaneous goals.
Defensive patent tactics
The core objective of a defensive patent strategy is to protect a company’s freedom to operate – that is, its ability to continue making and selling its own products without being blocked by a competitor’s patent or drawn into costly infringement litigation. Strategically placed defensive patents deter prospective infringers and act as barriers against competitors who might seek to claim similar technological ground.
Building a blocking portfolio
One of the most common defensive moves is accumulating a portfolio of patents broad enough that competitors cannot easily design around them. A company does not have to intend to commercialise every patented idea – the point is to prevent a rival from patenting the same or adjacent technology and then weaponising that patent against the original innovator. IBM’s long-standing practice of filing patents comprehensively across its technology space is a well-known example: the portfolio acts as a deterrent, making it strategically risky for competitors to challenge IBM in court.
Defensive publication
For innovations that a company does not wish to patent fully – perhaps because the commercial value does not justify filing costs – defensive publication is a strategic tool that discloses an invention publicly, placing it in the public domain so that nobody else can later obtain a patent over the same concept. Once published, the disclosure becomes prior art. This blocks competitors from claiming exclusivity over the idea, even though the disclosing company itself gives up any right to patent it.
In India, defensive publication is still a developing practice, but it is gaining traction among cost-conscious start-ups and research institutions that want to preserve their freedom to use a technology without bearing the full expense of patent prosecution and maintenance.
Cross-licensing as a defensive shield
When two companies each hold patents that the other needs, they often enter into cross-licensing agreements – granting each other rights to use the respective patents without payment. This is fundamentally a defensive tactic: it neutralises the threat of mutual infringement suits and allows both parties to continue operating. In technology-dense sectors like semiconductors and telecommunications, cross-licensing is so common that it effectively functions as an informal industry norm.
Freedom to operate (FTO) analysis
Underlying all defensive tactics is the concept of freedom to operate (FTO). Before launching a new product, companies typically commission an FTO analysis – a systematic review of existing patents to check whether the planned product would infringe any active rights. Under Section 48 of India’s Patents Act, patent owners hold exclusive rights to prevent third parties from making, using, or selling a patented invention – and an FTO review identifies whether any such rights could block a planned product. An FTO opinion guides R&D investment decisions and helps companies steer innovation away from heavily patented zones, reducing future dispute risk.
Offensive patent tactics
Whereas defensive tactics focus on protection, offensive tactics focus on generating direct revenue gains and protecting competitive advantages by actively asserting patent rights against others. Offensive patents are empowerment tools for companies seeking to actively protect market share and increase revenue – holding key patents enables a company to control access to essential technologies, creating obstacles for competitors.
Licensing for revenue
The most straightforward offensive tactic is licensing – granting a third party the right to use a patented technology in exchange for royalties or a lump-sum payment. An offensive patent strategy is essentially designed to stop competitors from entering a company’s proprietary technologies as well as its business sector, but licensing flips this logic: instead of simply excluding competitors, the patent holder monetises their access. Companies like Qualcomm and ARM derive a substantial portion of their revenue not from manufacturing products themselves but from licensing their patent portfolios to manufacturers worldwide.
Litigation and enforcement
When a patent holder identifies infringement and the infringer refuses to take a licence, litigation becomes the offensive tool. Patent infringement suits can result in injunctions that force a competitor to stop selling a product, as well as damages awards. In India, the Patents Act, 1970 provides for enforcement through infringement suits, and the 2005 Amendment significantly strengthened the product patent regime, making enforcement more viable – particularly in pharmaceuticals. An increasingly common approach is to send a cease-and-desist letter first, proposing a licensing arrangement as an alternative to litigation. If the infringer accepts, they become a paying licensee; if not, the matter proceeds to court.
Patent fencing and thickets
A more aggressive offensive tactic is building a patent thicket – a dense web of overlapping patents around a core technology that makes it very difficult for competitors to design around the key invention. In a patent fencing strategy, a company designs around a competitor’s core patent and then places additional patents all around its own, effectively suffocating the competitor’s ability to operate freely in that technological space. Pharmaceutical companies often use continuation patents – filing follow-on applications that extend protection to improvements or new formulations – to maintain market exclusivity well beyond the initial grant period.
Blocking competitors from key technology areas
Offensive tactics also include filing patents specifically to prevent rivals from entering a technology space, even if the patent holder has no immediate plans to commercialise the invention. This is sometimes called a tollgate strategy: the patent sits at the entry point of a technological pathway, and any competitor wishing to use that pathway must pay for access or find an alternative route. While aggressive, this approach is legally permissible and widely used in industries with rapid innovation cycles.
Transactional patent tactics
Transactional tactics take the broadest view of patents – treating them not merely as legal protections but as business assets that can attract financing, facilitate corporate transactions, and enhance a company’s reputation as an innovative enterprise. Unlike traditional protective approaches that focus primarily on preventing competitors from using proprietary technology, transactional strategies view patents as tradable assets that can generate revenue, facilitate market access, and create strategic partnerships.
Patents as collateral for financing
A strong patent portfolio carries quantifiable economic value, and companies – especially start-ups and early-stage innovators – can use that value to secure funding. Patents can be pledged as collateral for loans or used to demonstrate tangible innovation assets to venture capital investors. In India’s growing start-up ecosystem, where access to traditional financing can be challenging, a well-constructed patent portfolio can materially strengthen a funding pitch. It signals that the company has invested in R&D, that its innovations have been independently validated through the patent examination process, and that it holds legally defensible market advantages.
Buying and selling patents
The market for patent transactions – outright purchases and sales – has grown considerably over the past two decades. Companies acquire patents to fill gaps in their portfolios, to enter new technology areas quickly without building from scratch, or to bolster their defensive holdings. Conversely, selling patents that are no longer central to a company’s strategy can generate immediate cash and reduce the ongoing cost of portfolio maintenance. Patent auctions and brokered sales have become a recognised mechanism in this market, with dedicated platforms facilitating transactions between buyers and sellers globally.
Collaborative R&D and joint IP ownership
Transactional tactics also encompass collaborative innovation arrangements – joint development agreements, research consortia, and university-industry partnerships – where multiple parties contribute to a shared R&D effort and agree in advance on how any resulting patents will be owned and commercialised. In India, pharmaceutical companies frequently enter into partnerships with public research institutions and academic laboratories, with agreements specifying IP ownership and licensing rights to resulting innovations. These arrangements lower individual R&D costs while accelerating the pace of innovation.
Enhancing corporate image and credibility
A robust patent portfolio is a public signal. When a company holds dozens or hundreds of patents in a technical domain, it communicates to the market – customers, competitors, partners, and talent – that it is a serious and sustained innovator. Major corporations monitor competitors’ patent portfolios to understand their future innovation direction, and they use their own portfolios to strategically outmanoeuvre competition. This reputational dimension of patenting is a genuinely transactional benefit: the portfolio itself becomes a marketing and positioning asset, quite apart from any specific right it confers.
Choosing the right mix of tactics
No single tactic is universally appropriate. The right patent strategy depends on a company’s size, industry, stage of development, and competitive environment. Large firms usually adopt comprehensive patent strategies due to the availability of resources and money, whereas small firms implement effective yet cost-efficient strategies. A start-up with a single breakthrough product might prioritise defensive filing to protect its freedom to operate and offensive licensing to generate early revenue, while a large corporation might simultaneously maintain a defensive portfolio, run an active licensing programme, and use patents as assets in mergers and acquisitions.
What is clear is that aligning patent strategies with overall business objectives requires coordination across R&D, legal, and business development teams. Patents drafted in isolation from commercial strategy frequently end up as expensive documents that serve no real business purpose. The most effective patent tactics are those that are conceived alongside product development and business planning – not as an afterthought once innovation has already occurred.
The Indian context
India presents a distinctive landscape for patent tactics. Historically, patent litigation in India has been less common than in jurisdictions like the United States, partly because of procedural delays and the relatively lower volume of granted patents. However, this is changing. The Patents Act, 1970, as amended in 2005 and updated through the Patent Amendment Rules, 2025, has progressively strengthened the enforcement framework. The establishment of specialised IP divisions in Indian courts has made offensive litigation more viable. Meanwhile, India’s booming start-up sector is increasingly patent-aware, with founders recognising that a patent portfolio can be a decisive factor in attracting foreign investment and strategic partnerships.
Defensive publication, though underutilised in India compared to mature IP jurisdictions, offers a particularly cost-effective tool for resource-constrained innovators – a way to secure freedom to operate without bearing full filing and prosecution costs. As IP awareness grows among Indian businesses, all three categories of patent tactics are likely to see more deliberate and sophisticated use.
What do you think? If you were advising an Indian tech start-up with limited resources and a single breakthrough product, which patent tactic – defensive, offensive, or transactional – would you prioritise first, and why? And as India’s IP ecosystem matures, do you think companies will shift more decisively toward offensive and transactional strategies, or will defensive protection remain the primary focus?
References
- https://www.indiacode.nic.in/handle/123456789/1392?locale=en
- https://arapackelaw.com/patents/defensive-patent-strategy/
- https://www.mondaq.com/india/patent/1507530/defensive-publication-detailed-overview
- https://www.intepat.com/blog/innovation-inventions-defensive-publication
- https://www.maheshwariandco.com/blog/freedom-to-operate-search-in-india/
- https://iprd.evalueserve.com/blog/understanding-offensive-and-defensive-patents-a-strategic-approach-to-intellectual-property/
- https://sagaciousresearch.com/blog/offensive-vs-defensive-patent-strategies
- https://ssrana.in/ip-laws/patents/patent-infringement-india/
- https://www.greyb.com/blog/patent-filing-strategies/
- https://www.lexisnexisip.com/resources/patent-data-as-an-offensive-and-defensive-strategy/
- https://ssrana.in/ip-laws/patents/
Leave a Reply